| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.36B | -9.8% |
| Cost of Revenue | $2.73B | -5.5% |
| R&D Expense | $6.0M | -14.3% |
| SG&A Expense | $455.0M | -0.7% |
| Interest Expense | $75.0M | -32.4% |
| Pre-tax Income | $504.0M | +251.8% |
| Income Tax | $78.0M | +316.7% |
| Net Income | $426.0M | +243.9% |
| EPS (Basic) | $2.28 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $366.0M | -26.5% |
| Accounts Receivable | $493.0M | -11.8% |
| Current Assets | $1.25B | -24.4% |
| Total Assets | $2.60B | -17.8% |
| Current Liabilities | $744.0M | -14.3% |
| Long-term Debt | $615.0M | -50.7% |
| Total Liabilities | $1.61B | -32.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.0M | -156.2% |
| Capital Expenditures | $28.0M | -45.1% |
| Investing Cash Flow | $795.0M | +954.8% |
| Financing Cash Flow | -$877.0M | -982.7% |
| Free Cash Flow | -$78.0M | -305.3% |
| +261.7% |
| EPS (Diluted) | $2.23 | +258.2% |
| Stockholders' Equity |
| $839.0M |
| +33.4% |